33.80
+0.61
+(1.84%)
At close: January 14 at 2:53:44 PM CST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,303,601.98
4,129,753.98
3,867,922.43
3,812,199.29
3,142,634.47
Cost of Revenue
2,860,560.09
2,670,119.09
2,500,743.88
2,308,240.72
1,954,135.07
Gross Profit
1,443,041.90
1,459,634.90
1,367,178.55
1,503,958.56
1,188,499.40
Operating Expense
1,064,912.14
868,592.14
792,246.18
757,281.45
550,011.84
Operating Income
378,129.76
591,042.76
574,932.36
746,677.12
638,487.56
Net Non Operating Interest Income Expense
-5,734.60
24,933.40
105,880.41
-22,982.30
-101,402.47
Pretax Income
520,702.97
741,510.97
677,582.28
613,456.86
483,440.81
Tax Provision
148,862.22
183,614.22
204,789.74
255,879.32
144,849.79
Net Income Common Stockholders
486,710.59
634,983.59
949,802.53
1,154,516.74
558,827.82
Diluted NI Available to Com Stockholders
486,710.59
634,983.59
949,802.53
1,154,516.74
558,827.82
Basic EPS
4.58
5.88
8.80
9.36
4.53
Diluted EPS
4.58
5.88
8.80
9.36
4.53
Basic Average Shares
106,006.69
107,938.97
107,938.97
123,281.75
123,281.75
Diluted Average Shares
106,006.69
107,938.97
107,938.97
123,281.75
123,281.75
Total Expenses
3,925,472.22
3,538,711.22
3,292,990.06
3,065,522.17
2,504,146.91
Net Income from Continuing & Discontinued Operation
486,710.59
634,983.59
949,802.53
1,154,516.74
558,827.82
Normalized Income
297,885.42
480,224.82
474,424.53
529,045.84
354,208.92
Interest Income
70,087.43
100,312.43
181,829.74
53,842.88
19,229.40
Interest Expense
75,822.03
75,379.03
75,949.33
76,825.18
120,631.87
Net Interest Income
-5,734.60
24,933.40
105,880.41
-22,982.30
-101,402.47
EBIT
596,525.00
816,890.00
753,531.61
690,282.03
604,072.68
EBITDA
788,655.29
995,505.29
922,800.38
867,076.86
927,837.80
Reconciled Cost of Revenue
2,860,560.09
2,670,119.09
2,500,743.88
2,308,240.72
1,954,135.07
Reconciled Depreciation
192,130.29
178,615.29
169,268.77
176,794.83
323,765.12
Net Income from Continuing Operation Net Minority Interest
371,841.87
557,897.87
472,792.13
357,605.67
338,568.14
Total Unusual Items Excluding Goodwill
103,564.08
103,564.08
-2,332.00
-101,222.23
-22,343.97
Total Unusual Items
103,564.08
103,564.08
-2,332.00
-637.63
-22,343.97
Normalized EBITDA
685,091.21
891,941.21
925,132.38
867,714.49
950,181.77
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
29,607.62
25,891.02
-699.60
-30,366.67
-6,703.19
12/31/2020 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FREA.F Fresenius SE & Co. KGaA
8.55
+0.59%
LIK.DE LIMES Schlosskliniken AG
336.00
0.00%
DANE.TA Danel (Adir Yeoshua) Ltd
42,870.00
-0.74%
MCOV-B.ST Medicover AB (publ)
197.20
+2.28%
6H90.MU Healwell AI Inc
1.1600
+6.91%
INNV InnovAge Holding Corp.
3.6900
+1.93%
LAS-CONDES.SN Clínica Las Condes S.A.
12,042.00
+0.48%
LWSCF Sienna Senior Living Inc.
10.22
+0.39%
EMEIS.PA EMEIS
5.27
-1.16%
PHA.V Premier Health of America Inc.
0.1450
0.00%